14 Hrs
Source:
أخبار الصين
أخبار الصين
Ready to play
Ready to play
An Australian study found that treatment for triple-negative breast cancer, one of the most aggressive and rapidly spreading types, may require measuring levels of the molecule "miR-342," which contributes to promoting the disease's spread when decreased. Research has shown that restoring "miR-342" levels reduced the cancer's metastasis to other organs such as the lungs and bones. Additionally, the drug "Palbociclib" has demonstrated effectiveness in decreasing the metastatic growth of tumors when levels of this molecule are low, potentially opening the door to repurposing existing drugs to treat an especially severe form of breast cancer.
Notice: This Is an AI-Generated Summary
Comments (0)